Hydraderm for Androgenic Alopecia

  • STATUS
    Recruiting
  • End date
    Mar 21, 2024
  • participants needed
    40
  • sponsor
    University of Minnesota
Updated on 8 July 2022
androgenic alopecia

Summary

The study will be focused on evaluating the use of hydradermabrasion on the scalp. The study aims to assess the effect of this treatment on scalp health and hair growth.

Details
Condition Androgenic Alopecia
Treatment Venus Glow
Clinical Study IdentifierNCT05426629
SponsorUniversity of Minnesota
Last Modified on8 July 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Participants who can give voluntary, written informed consent to participate in this study and from whom consent has been obtained including HIPAA Authorization
Participants who have androgenetic alopecia
Healthy men and women, ages 18 - 65 years of age
Participants who understand the study and can follow study instructions and are willing to attend the required study visits
Participants who agree to be photographed for research purposes and their identity may not be concealed in these photographs
Participants who agree to continue their same treatment they are on at the baseline visit for androgenetic alopecia, for the entire duration of the study without plans to stop, change or add additional treatments
Participants who agree to use the same shampoo for the duration of the study

Exclusion Criteria

Participants who have not had a change to hair loss treatment for 4 months prior to study enrollment
Participants who have an active or known skin inflammation or infection within the treatment area
Participants who have an active or known acute skin allergies
Participants who have any other scalp conditions including eczema, psoriasis, infection, or scars within the treatment area
Participants of child-bearing potential who are not using an approved method of birth control (oral contraceptives, IUD, contraceptive implant, barrier methods with spermicide or abstinence). Females of non-childbearing potential are defined as post-menopausal (absence of menstrual bleeding for one year), hysterectomy, or bilateral oophorectomy
Participants who are pregnant, planning to become pregnant or breastfeeding. A urine pregnancy test will be done to rule out pregnancy
Immunosuppression
Participants who are HIV+ / Hepatitis B + / Hepatitis C+
Participants who have been diagnosed or have a known history of any hematopathology disorders
Participants who have been diagnosed or have a known history of haemostasis disorders
Participants who have been diagnosed or have a known history of an autoimmune diseases
Participants who are undergoing chemotherapy
Participants with a history of any skin cancer on the scalp
Participants who have had skin biopsy or procedure on scalp in last month
Participants who have an implantable devices such as a deep brain stimulator in or other implantable device on or near treatment area
Non-English speakers
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note